How DOJ Built Its Generic Price Fixing Case: Cooperating Witnesses At Competitors
Former sales and marketing exec at Taro Pharmaceuticals is latest exec charged with participating in price fixing conspiracies.
You may also be interested in...
Complaint names 26 generic dermatologic drug manufacturers and 10 individual executives as defendants, alleging they engaged in a widespread conspiracy to artificially inflate and manipulate prices. State attorneys general say that structural and personnel changes at the companies fostered and facilitated collusion.
$195m deferred prosecution agreement with the US DOJ could be followed by civil settlement that's almost as large, illustrating the strong evidence in the generic price-fixing investigation thus far.
Rising Pharmaceuticals agrees to pay $3.1m, admits to conspiring to fix prices for hypertension drug, and enters into deferred prosecution agreement. Pfizer asks court to be removed from complaint by state AGs.